发明授权
- 专利标题: Stereospecific reduction of sapogen-3-ones
- 专利标题(中): 皂角苷3-酮的立体特异性还原
-
申请号: US10531086申请日: 2003-04-28
-
公开(公告)号: US07718792B2公开(公告)日: 2010-05-18
- 发明人: Philip James Gunning , Peter David Tiffin
- 申请人: Philip James Gunning , Peter David Tiffin
- 申请人地址: GB Cambridgeshire
- 专利权人: Phytopharm PLC
- 当前专利权人: Phytopharm PLC
- 当前专利权人地址: GB Cambridgeshire
- 代理机构: Husch Blackwell Sanders LLP Welsh & Katz
- 优先权: GB0225106.4 20021028; GB0301505.4 20030122
- 国际申请: PCT/GB03/01780 WO 20030428
- 国际公布: WO2004/037845 WO 20040506
- 主分类号: C07J71/00
- IPC分类号: C07J71/00
摘要:
A method to stereospecifically prepare a steroidal sapogenin or a derivative thereof by reducing a 3-keto,5β-H steroidal sapogenin with a hindered organoborane or an organo-aluminium hydride. A 3β-hydroxy,5β-H steroidal sapogenin or derivative thereof may be prepared by reducing the 3-keto,5β-H steroidal sapogenin using as reducing agent a relatively highly hindered organoborane reagent or by SN 2 inversion of a 3α-hydroxy,5β-H steroidal sapogenin or derivative thereof. The organo-aluminium hydride may be used to prepare a 3α,5β-H steroidal sapogenin or derivative thereof. The invention provides a convenient route to useful steroidal sapogenins such as sarsasapogenin, episarsasapogenin, smilagenin, epismilagenin and esters thereof, from readily available or easily preparable starting materials (e.g. diosgenone, preparable from diosgenin).
公开/授权文献
- US20060041119A1 Stereospecific reduction of Sapogen-3-ones 公开/授权日:2006-02-23
信息查询